Condition: Irritable Bowel Syndrome · Diarrhea · Sponsor: Madhusudan (Madhu) Grover, MBBS
The purpose of this study is to learn the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity and containing the bacteria Alistipes putredinis in patients with irritable bowel syndrome (IBS) and high proteolytic activity. Proteolytic activity is the breakdown of proteins into smaller polypeptides or amino acids.
This description comes directly from the study's public registry record.
Jonah Pedelty, MS · 507-538-7774 · pedelty.jonah@mayo.edu
Margaret Breen-Lyles · 507-422-5759 · breen-lyles.margaret@mayo.edu
Always discuss trial participation with your own doctor first.
| Mayo Clinic in Minnesota | Rochester, Minnesota, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05776914